Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
Curebase
Decentralized clinical trial platform combining eClinical software with a distributed network of research sites.
Curebase, founded in 2017 and headquartered in San Francisco, California, provides a decentralized and hybrid clinical trial platform — including eConsent and virtual visit tooling — combined with a distributed network of research clinics. The company raised a Series B in 2022. It does not publish a public security certification page, so request documentation during evaluation.
- Headquarters
- San Francisco, United States
- Founded
- 2017
- Deployment options
- cloud
- Website
- https://www.curebase.ai
- https://www.linkedin.com/company/curebase
Categories
AI Use Cases
- Digital/Decentralized Trials
Vendor Scorecard
50% — Partial coverage. Coverage score — how completely Atlas documents Curebase across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Deployment & Hosting — Documented
cloud
Pricing Transparency — Not documented by Atlas
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Implementation & Onboarding — Not documented by Atlas
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Organization & Role Fit — Documented
Biotech Startup, Mid-Size Biotech, CRO / CDMO, Clinical Operations
Solution Scope — Documented
Patient Recruitment
Company Viability — Partially documented
Series B, Founded 2017
Always ask the vendor
Not captured in Atlas data — confirm directly. Excluded from the score above.
Data Rights & IP
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Model Credibility & Explainability
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?
Questions to Ask This Vendor
- Which study types and therapeutic areas has the platform run end to end?
- How is the distributed site network managed for quality and oversight?
- What security and compliance documentation can be provided?
- How do decentralized visit data flow into our existing data management systems?